Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Structural Heart Disease: Comparing LAA occluder devices | LAAO outcomes among women | TEER vs. surgery

News You Need to Know Today
Structural Heart Disease: Comparing LAA occluder devices | LAAO outcomes among women | TEER vs. surgery
Thursday, September 16, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Structural Heart Disease

Amulet vs. Watchman: LAA occluder devices compared in new head-to-head trial

The Amulet's implantation success rate and LAA closure rate were both higher than the first-generation Watchman device, researchers reported.

READ MORE >
IVUS guidance during DES implantation boosts long-term outcomes in new study
Share on Twitter Share on Facebook Share on Linkedin

Amulet vs. Watchman: LAA occluder devices compared in new head-to-head trial

Share on Twitter Share on Facebook Share on Linkedin
IVUS guidance during DES implantation boosts long-term outcomes in new study
The Amulet's implantation success rate and LAA closure rate were both higher than the first-generation Watchman device, researchers reported.
READ MORE >

Valve-in-valve TMVR an effective option for patients with mitral prosthesis dysfunction

Adjusted mortality and perioperative complications were both lower among patients undergoing ViV TMVR.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Valve-in-valve TMVR an effective option for patients with mitral prosthesis dysfunction

Share on Twitter Share on Facebook Share on Linkedin
Adjusted mortality and perioperative complications were both lower among patients undergoing ViV TMVR.
READ MORE >

AI model classifies patients by aortic stenosis severity, could improve AVR timing

The classifier was developed using imaging data from nearly 2,000 patients. 

READ MORE >
artificial-intelligence-3382507_960_720.jpg
Share on Twitter Share on Facebook Share on Linkedin

AI model classifies patients by aortic stenosis severity, could improve AVR timing

Share on Twitter Share on Facebook Share on Linkedin
artificial-intelligence-3382507_960_720.jpg
The classifier was developed using imaging data from nearly 2,000 patients. 
READ MORE >

LAAO outcomes significantly worse among women

Researchers tracked data from more than 49,000 patients who underwent LAAO from January 2016 to June 2019.

READ MORE >
In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.
Share on Twitter Share on Facebook Share on Linkedin

LAAO outcomes significantly worse among women

Share on Twitter Share on Facebook Share on Linkedin
In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.
Researchers tracked data from more than 49,000 patients who underwent LAAO from January 2016 to June 2019.
READ MORE >

Survival rates similar when treating secondary MR with TEER or surgery

Surgical mitral valve repair, however, was also associated with multiple benefits.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Survival rates similar when treating secondary MR with TEER or surgery

Share on Twitter Share on Facebook Share on Linkedin
Surgical mitral valve repair, however, was also associated with multiple benefits.
READ MORE >

Echocardiography-guided LAAC boosts patient outcomes

LAAC patients see clear benefits when echocardiographic guidance (EG) is used in addition to fluoroscopy.

READ MORE >
surgery-676375_1920.jpg
Share on Twitter Share on Facebook Share on Linkedin

Echocardiography-guided LAAC boosts patient outcomes

Share on Twitter Share on Facebook Share on Linkedin
surgery-676375_1920.jpg
LAAC patients see clear benefits when echocardiographic guidance (EG) is used in addition to fluoroscopy.
READ MORE >

How delayed peridevice leak after LAAC affects patient outcomes

Delayed PDL was identified in more than 10% of patients undergoing the procedure. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

How delayed peridevice leak after LAAC affects patient outcomes

Share on Twitter Share on Facebook Share on Linkedin
Delayed PDL was identified in more than 10% of patients undergoing the procedure. 
READ MORE >

Aortic valve replacement on the rise among patients with Alzheimer’s disease, related dementias

The increasing popularity of TAVR appears to be the biggest reason for this shift.

READ MORE >
Treating elderly atrial fibrillation (AFib) patients—even those who are traditionally ineligible for direct oral anticoagulants (DOACs)—with a very low dose of edoxaban is associated with improved outcomes, according to new research published in JAMA Network Open.
Share on Twitter Share on Facebook Share on Linkedin

Aortic valve replacement on the rise among patients with Alzheimer’s disease, related dementias

Share on Twitter Share on Facebook Share on Linkedin
Treating elderly atrial fibrillation (AFib) patients—even those who are traditionally ineligible for direct oral anticoagulants (DOACs)—with a very low dose of edoxaban is associated with improved outcomes, according to new research published in JAMA Network Open.
The increasing popularity of TAVR appears to be the biggest reason for this shift.
READ MORE >

Why 'leaky' heart valves in pregnant women should not be ignored

The new analysis, published in the American Journal of Cardiology, explored the increased risk of adverse obstetric and cardiovascular events among pregnant women.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Why 'leaky' heart valves in pregnant women should not be ignored

Share on Twitter Share on Facebook Share on Linkedin
The new analysis, published in the American Journal of Cardiology, explored the increased risk of adverse obstetric and cardiovascular events among pregnant women.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

More recalls announced due to high-risk device | AATS helps surgeons manage a major complication | How guidelines impact care
Week in Review: TAVR or SAVR? | Key trends in cardiac CT | Fraud allegations lead to $6.7M settlement | CTO PCI
FDA clears intravascular imaging tech | Key trends in cardiac CT | Heartflow sues rival | Opportunistic screening
Vascular specialist agrees to pay $6.7M | Robotic heart surgery: Worth the cost? | E-cigarette concerns | Heart tech on display
FDA clears next-gen heart device | Catching up with SCAI's new president | A warning for cath labs | Late-breaking PCI data
New data confirm long-term durability of Resilia tissue | CCTA delivers clarity, better outcomes | Cannabis use & heart attacks
TAVR Highlights: Predicting long-term outcomes | SCAI, ACC & STS share a message | Weight loss drug linked to key benefits

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …6
    • Page 7
    • Page 8
    • Page 9
    • Current page 10
    • Page 11
    • Page 12
    • Page 13
    • Page 14 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme